ReShape Lifesciences Inc.

0.39
-0.05 (-11.46%)
At close: Mar 28, 2025, 3:59 PM
0.39
1.81%
After-hours: Mar 28, 2025, 06:57 PM EDT

ReShape Lifesciences Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Net Income -11.39M -46.21M -61.93M -21.63M -74.21M -35.27M -33.82M -23.36M -25.5M -26.13M -25.78M -23.46M -26M -17.35M -31.93M -37.87M -28.58M -17.69M -11.22M
Depreciation & Amortization 154K 2.15M 1.97M 1.67M 1.71M 440.56K 925.46K 139.58K 188.61K 188.9K 174.63K 226.99K 303.97K 375.76K 424.35K 513.06K 992.37K 95.85K 143.23K
Stock-Based Compensation 766K 2.09M 12.23M 1.32M 2.31M 3.1M 4.44M 2.33M 6.94M 6.32M 5.95M 4.23M 2.89M 2.56M 2.44M 2.52M n/a n/a n/a
Other Working Capital -337K 770K -608K 929K -1.14M -929.62K 1.58M 960.24K -783.2K -316.33K 787.12K -3.2M -176.99K 571.1K -659K 698.87K -11.07K 1.21M 768.83K
Other Non-Cash Items -2.39M 19.79M 34.64M 10.17M 58.56M 6.83M 4.73M -3.51M -3.3M 6.44M 8.03K 4.44M -26M -158.83K 3.64M 3.17M 4.23M 157.81K 25.04K
Deferred Income Tax 28K -423K -60K -86K -1.14M -3.45M -2.31M 1.86M 826.62K -6.32M 199.59K -4.22M 26.24M 440.48K 1.5M -2.52M n/a n/a n/a
Change in Working Capital -4.13M 709K -2.74M 6K -1.43M 857.22K 1.45M 1.89M -1.77M 113.38K 1.02M -3.68M 2.63M 461.15K -732.71K 515.83K -11.07K 1.21M 768.83K
Operating Cash Flow -16.96M -21.9M -15.38M -8.55M -14.2M -27.49M -24.59M -20.66M -22.61M -19.38M -18.43M -22.48M -19.94M -13.66M -24.66M -33.67M -23.37M -16.23M -10.28M
Capital Expenditures -43K -131K -352K -390K -14K -49.58K -137.12K -14K -38.91K -88.68K -416.01K -76.39K -252.27K -2.59K -186.98K -244.44K -800.39K -634.97K -449.81K
Acquisitions n/a 39K 2.21M -2M -2M -10.28M -6.23M n/a 6K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a -39K n/a n/a n/a -9.1M -94.61M -18.9M -18.59M n/a n/a n/a -5.01M n/a n/a -10.31M -6.94M -20.04M n/a
Sales Maturities Of Investments n/a 639K n/a n/a 2.55M 29.9M 73.8M 25.45M 21.5M n/a n/a 1M 4M n/a 5.23M 13.39M 15.99M 3M n/a
Other Investing Acitivies 33K -600K 2.21M n/a -2.55M -20.8M 20.81M -6.55M n/a n/a 200K 1M 6.33M -6.53M n/a n/a n/a n/a n/a
Investing Cash Flow -10K -92K 1.85M -2.39M -2.01M -10.33M -6.37M -14K -38.91K -88.68K -216.01K 923.61K 5.07M -6.53M 5.04M 2.83M 8.25M -17.67M -449.81K
Debt Repayment n/a n/a -9.5M 10.46M n/a n/a n/a 16.8M 5M -4M -3M 4.59M -922K -1.89M -6.78M 3.33M 7.21M 1.34M 8.38M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.21M -2.6M -898.97K n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 17.57M 2.49M 42.8M 620K 13.18M -4.54M 31.34M -749.79K -8.7M 1.96M -1.42M 5.73M -1.08M 5.8M 20.86M -164.83K -1.75M -1.49M -40.05K
Financial Cash Flow 17.57M 3.13M 33.3M 11.07M 13.66M 33.2M 37.81M 16.05M 18.95M 7.79M 19.63M 15.38M 12.52M 36.42M 13.18M 3.16M 46.32M 40.72M 16.11M
Net Cash Flow 604K -18.86M 19.81M 22K -2.56M -4.62M 6.85M -4.62M -3.69M -11.68M 988.7K -6.18M -2.35M 16.22M -6.44M -27.68M 31.2M 6.82M 5.39M
Free Cash Flow -17M -22.03M -15.73M -8.94M -14.21M -27.54M -24.73M -20.67M -22.64M -19.47M -18.84M -22.56M -20.19M -13.67M -24.84M -33.91M -24.17M -16.86M -10.73M